4/2/01
Total Hits: 0
4/3/01
Total Hits: 0
4/4/01
Total Hits: 2
- [1] fr04ap01N Draft ``Guidance for Industry: Reports
on the Status of
- Size: 13069 , Score: 1000 , HTML
- [2] fr04ap01N Studies of Adverse Effects of Marketed Drugs; Availability of
- Size: 33448 , Score: 321 , HTML
4/5/01
Total Hits: 0
4/6/01
Total Hits: 1
- [1] fr06ap01N Guidance for Hospitals, Nursing Homes,
and Other Health Care
- Size: 4501 , Score: 510 , HTML
4/9/01
Total Hits: 0
4/10/01
Total Hits: 1
- [1] fr10ap01N Parke-Davis Pharmaceutical Research
et al.; Withdrawal of
- Size: 1809 , Score: 392 , HTML
4/11/01
Total Hits: 0
4/12/01
Total Hits: 0
4/13/01
Total Hits: 0
4/16/01
Total Hits: 0
4/17/01
Total Hits: 0
4/18/01
Total Hits: 0
4/19/01
Total Hits: 0
4/20/01
Total Hits: 0
4/23/01
Total Hits: 2
- [1] fr23ap01N Draft Guidance for Industry on Using
FDA-Approved Patient
- Size: 6173 , Score: 1000 , HTML
- [2] fr23ap01R Public Hearing Before a Public Advisory Committee; Examination of
- Size: 1975 , Score: 606 , HTML
4/24/01
Total Hits: 3
- [1] fr24ap01N Exchange of Letters Between the Food
and Drug Administration and
- Size: 2323 , Score: 952 , HTML
- [2] fr24ap01N Preparation for ICH Meetings in Tokyo, Japan, Including Progress
- Size: 6243 , Score: 754 , HTML
- [3] fr24ap01R Additional Safeguards for Children in Clinical Investigations of
- Size: 79583 , Score: 542 , HTML
4/25/01
Total Hits: 0
4/26/01
Total Hits: 0
4/27/01
Total Hits: 1
- [1] fr27ap01N Cardiovascular and Renal Drugs Advisory
Committee; Notice of
- Size: 3159 , Score: 557 , HTML
4/30/01
Total Hits: 0
 |